133 results in Exploration of Drug Science
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Case Report
Histological diagnosis of primary biliary cholangitis in one patient without cholestasis alterations: a case report that escaped guidelines
Matteo Biagi ... Pietro Andreone
Published: January 22, 2024 Explor Drug Sci. 2024;2:1–5
This article belongs to the special issue Innovative Therapeutics in Hepato-Gastroenterology
Open Access
Review
Harnessing the power of seaweed: unveiling the potential of marine algae in drug discovery
Leonel Pereira, Ana Valado
Published: December 28, 2023 Explor Drug Sci. 2023;1:475–496
Open Access
Case Report
Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case report
Elena Franchi ... Pietro Andreone
Published: December 27, 2023 Explor Drug Sci. 2023;1:468–474
This article belongs to the special issue Innovative Therapeutics in Hepato-Gastroenterology
Open Access
Review
Electrospun short fibers: a new platform for cancer nanomedicine applications
Yifan Huang ... Xiangyang Shi
Published: December 27, 2023 Explor Drug Sci. 2023;1:454–467
Open Access
Original Article
Rational design of novel phenol ether derivatives as non-covalent proteasome inhibitors through 3D-QSAR, molecular docking and ADMET prediction
Miao Yuan ... Ping Cheng
Published: December 27, 2023 Explor Drug Sci. 2023;1:435–453
This article belongs to the special issue Machine Learning for Drug Science
Open Access
Original Article
Hybrid azole-based conjugates as upcoming anticancer and antimicrobial agents
Luís M. T. Frija ... Patrícia Rijo
Published: November 23, 2023 Explor Drug Sci. 2023;1:420–434
Open Access
Original Article
Insights into the binding selectivity of harzianoic acids A and B to tetraspanin CD81
Gérard Vergoten, Christian Bailly
Published: November 01, 2023 Explor Drug Sci. 2023;1:405–419
Open Access
Original Article
Creation and interpretation of machine learning models for aqueous solubility prediction
Minyi Su, Enric Herrero
Published: October 30, 2023 Explor Drug Sci. 2023;1:388–404
This article belongs to the special issue Machine Learning for Drug Science
Open Access
Review
Therapeutic proteins immunogenicity: a peptide point of view
Feliciana Real-Fernandez ... Paolo Rovero
Published: October 26, 2023 Explor Drug Sci. 2023;1:377–387
This article belongs to the special issue Bioactive Peptides discovery and development
Open Access
Review
Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies
Atri Das ... Shantanabha Das
Published: October 24, 2023 Explor Drug Sci. 2023;1:336–376
This article belongs to the special issue Exploring Potential Drugs from Natural Products
Open Access
Original Article
Late-stage diversification strategy for the synthesis of peptide acids and amides using hydrazides
Shoko Tanaka ... Kohei Sato
Published: October 09, 2023 Explor Drug Sci. 2023;1:322–335
This article belongs to the special issue Bioactive Peptides discovery and development
Open Access
Case Report
Grade IV oral mucositis treatment with Brazilian green propolis mucoadherent gel
Diogo Alvarenga Silva ... Vagner Rodrigues Santos
Published: October 9, 2023 Explor Drug Sci. 2023;1:312–321
Open Access
Original Article
Electrochemical properties of hydroxyapatite immobilization material for potential cytosensor fabrication
Dennis Adusei ... Elvis K. Tiburu
Published: September 21, 2023 Explor Drug Sci. 2023;1:299–311
Open Access
Case Report
Single or multiple treatments with lusutrombopag in subjects with thrombocytopenia and chronic liver disease needing an invasive procedure
Davide Scalabrini ... Pietro Andreone
Published: August 30, 2023 Explor Drug Sci. 2023;1:292–298
This article belongs to the special issue Innovative Therapeutics in Hepato-Gastroenterology
Open Access
Commentary
Could flavonoid aglycones prevent the absorption of flavonoid glycosides by inhibiting sodium-dependent glucose transporter-1 in the small intestine?
Katrin Sak
Published: August 30, 2023 Explor Drug Sci. 2023;1:287–291
Open Access
Original Article
In silico study about β-amyloid’s role in Alzheimer’s disease and glaucoma and prediction of its interactions with glaucoma related proteins
Nancy Maurya
Published: August 29, 2023 Explor Drug Sci. 2023;1:276–286
This article belongs to the special issue Machine Learning for Drug Science
Open Access
Review
Natural compounds from medicinal plants against COVID-19
Anton Kolodnitsky ... Vladimir Poroikov
Published: August 28, 2023 Explor Drug Sci. 2023;1:253–275
This article belongs to the special issue Exploring Potential Drugs from Natural Products
Open Access
Review
Iron depletion in “metabolic fatty liver syndromes”: a strong biological rationale with disappointing liver outcomes
Amedeo Lonardo
Published: August 28, 2023 Explor Drug Sci. 2023;1:239–252
Open Access
Review
The protective role of GLP-1 in neuro-ophthalmology
Sohum Sheth ... Brandon Lucke-Wold
Published: August 28, 2023 Explor Drug Sci. 2023;1:221–238
Open Access
Original Article
A dextrorotatory residues-incorporated bioactive dodecapeptide against enterohemorrhagic Escherichia coli
Ping Zeng ... Lanhua Yi
Published: June 30, 2023 Explor Drug Sci. 2023;1:210–220
This article belongs to the special issue Bioactive Peptides discovery and development
PreviousJournal Information